Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ALTE

ALTE (ALTE) Stock Price, News & Analysis

ALTE logo

About ALTE Stock (NASDAQ:ALTE)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ALTE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ALTE and its competitors with MarketBeat's FREE daily newsletter.

ALTE Stock News Headlines

Form 6K ALTERITY THERAPEUTICS LTD For: 15 August
Insider Sale: CIO of $DXPE Sells 5,000 Shares
Biotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B market
A small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of the market’s most overlooked opportunities today. NanoViricides, Inc. (NYSE: NNVC) is advancing NV-387, a broad-spectrum antiviral now in human trials, with activity against COVID-19, RSV, influenza, measles, and most recently Mpox. With Phase II trials approved in Africa for the deadliest Mpox strain, the timing couldn’t be more critical.
See More Headlines

ALTE Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that ALTE investors own include BioCryst Pharmaceuticals (BCRX), Alkaline Water (WTER) and PolyMet Mining (PLM).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:ALTE
CIK
1141719
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:ALTE) was last updated on 8/18/2025 by MarketBeat.com Staff
From Our Partners